Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer.
Krens SD, van Erp NP, Groenland SL, Moes DJAR, Mulder SF, Desar IME, van der Hulle T, Steeghs N, van Herpen CML.
Krens SD, et al. Among authors: van erp np, van herpen cml, van der hulle t.
BMC Cancer. 2022 Mar 2;22(1):228. doi: 10.1186/s12885-022-09338-1.
BMC Cancer. 2022.
PMID: 35236333
Free PMC article.